(Q44802218)

6 December 2017

title

Inhaled iloprost: in primary pulmonary hypertension (English)

1 reference

6 December 2017

2

Antona J Wagstaff

1 reference

6 December 2017

David R Goldsmith

1

1 reference

6 December 2017

publication date

1 January 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

64

1 reference

6 December 2017

issue

7

1 reference

6 December 2017

page(s)

763-73; discussion 774-5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464070-00009

6 December 2017

exact match

0 references

cites work

Current management of primary pulmonary hypertension

1 reference

12 December 2020

Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

1 reference

12 December 2020

No pharmacokinetic interaction between iloprost and digoxin

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Inhaled iloprost for severe pulmonary hypertension

1 reference

12 December 2020

Current management of primary pulmonary hypertension

1 reference

12 December 2020

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension

1 reference

12 December 2020

Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation

1 reference

12 December 2020

Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise

1 reference

12 December 2020

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment

1 reference

12 December 2020

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

1 reference

12 December 2020

Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.

1 reference

12 December 2020

Current and emerging therapy for primary pulmonary hypertension

1 reference

12 December 2020

Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue

1 reference

12 December 2020

Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs

1 reference

12 December 2020

Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

1 reference

12 December 2020

Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension

1 reference

12 December 2020

Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension

1 reference

12 December 2020

The new clinical trials on pharmacological treatment in pulmonary arterial hypertension.

1 reference

12 December 2020

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

1 reference

12 December 2020

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

12 December 2020

Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.

1 reference

12 December 2020

Aerosolized iloprost for primary pulmonary hypertension

1 reference

12 December 2020

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

12 December 2020

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

1 reference

12 December 2020

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

1 reference

12 December 2020

10.2165/00003495-200464070-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

6 December 2017

1006898011

0 references

Fatcat ID

release_ad4sgryib5bf3prjw5fsdzj32u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ad4sgryib5bf3prjw5fsdzj32u

24 November 2022

mapped directly with Wikidata item

1 reference